1-4 of 4
Laura M Moesbergen
Close
Sort by
Journal Articles

MCL-1 Inhibition Is Highly Effective Against Multiple Myeloma Cells from Poor Prognosis Patients

Anne Slomp, MSc, Laura M Moesbergen, Constantijn J.M. Halkes, MD, Pieter Sonneveld, MD PhD, Monique C Minnema, MD PhD, Victor Peperzak, PhD MSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 1916.
https://doi.org/10.1182/blood-2018-99-117990
Published: 2018
Journal Articles

Imbalance in Alternative Splicing of MCL-1 Inhibits Apoptosis in Diffuse Large B-Cell Lymphoma

Nicolle H Rekers, Laura M Moesbergen, Nathalie J Hijmering, Wim Vos, Joost Oudejans, Gert J. Ossenkoppele, Chris JLM Meijer, MD PhD, Saskia AGM Cillessen, PhD
Journal: Blood
Blood (2014) 124 (21): 5424.
https://doi.org/10.1182/blood.V124.21.5424.5424
Published: 2014
Journal Articles

Bortezomib Restores Defective Apoptosis by Upregulation of Noxa in Enteropathy-Associated T-Cell Lymphoma

Laura R de Baaij, MD, Marijn Radersma, MD, Jolanda MW van de Water, MD, Kim BJ Groot, Nathalie J Hijmering, Laura M Moesbergen, Otto J Visser, MD, Joost J Oudejans, MD, PhD, Chris JJ Mulder, MD, PhD, Chris JLM Meijer, MD, PhD, Saskia AGM Cillessen, PhD
Journal: Blood
Blood (2011) 118 (21): 2722.
https://doi.org/10.1182/blood.V118.21.2722.2722
Published: 2011
Journal Articles

Bortezomib Induces Caspase-9-Mediated Apoptosis through Activation of the BH3-Only Proteins Noxa, Bik and Puma In Both ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma Cells

Saskia AGM Cillessen, PhD, Nathalie J Hijmering, Laura M Moesbergen, Gert J. Ossenkoppele, MD, PhD, Joost J Oudejans, MD, PhD, Chris JLM Meijer, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2847.
https://doi.org/10.1182/blood.V116.21.2847.2847
Published: 2010